Lehnert, M., Ludwig, H., & Zojer, N. (2009). Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma. Dove Medical Press.
Chicago Style CitationLehnert, Martina, Heinz Ludwig, i Niklas Zojer. Update On the Rational Use of (90)Y-ibritumomab Tiuxetan in the Treatment of Follicular Lymphoma. Dove Medical Press, 2009.
Cita MLALehnert, Martina, Heinz Ludwig, i Niklas Zojer. Update On the Rational Use of (90)Y-ibritumomab Tiuxetan in the Treatment of Follicular Lymphoma. Dove Medical Press, 2009.
Atenció: Aquestes cites poden no estar 100% correctes.